Background Successful local therapy for oligometastases may lead to longer survival. The
purpose of this multicentre retrospective study was to investigate factors affecting the local …

Clinical trials frequently include multiple end points that mature at different times. The initial
report, typically based on the primary end point, may be published when key planned co …

Objective To report our institutional experience with five fractions of daily 8-12 Gy
stereotactic body radiotherapy (SBRT) for the treatment of oligometastatic cancer to the lung …

Metastatic lung disease has long been the preserve of systemic treatments, local treatments
being considered in a purely palliative intention. Several studies have objectified benefit to …

Stereotactic ablative radiotherapy (SABR) may improve survival in patients with inoperable
pulmonary oligometastases. However, the impact of pulmonary oligometastatic status after …

Purpose The purpose of this study is to evaluate the feasibility, efficacy and toxicity of SBRT
for treatment of unresectable hepatic or lung metastases regardless of their primary tumor …

Introduction Stereotactic body radiation therapy is an emerging noninvasive technique for
the treatment of oligometastatic cancer. The use of small numbers of large doses achieve a …

Lung metastases are the second most common malignant neoplasms of the lung. It is
estimated that 20–54% of cancer patients have lung metastases at some point during their …

INTRODUCTION: Stereotactic body radiation therapy (SBRT) has an emerging role in
patients affected with pulmonary metastases. Purpose of this study was to evaluate efficacy …

Purpose The lung is the most frequent site of metastasis in patients with sarcoma.
Pulmonary metastasectomy is the most common treatment performed. Stereotactic body …